Author: admin

  • Apnimed to Participate in the 5th Annual Needham Private Biotech and MedTech Company Virtual 1×1 Forum

    Apnimed to Participate in the 5th Annual Needham Private Biotech and MedTech Company Virtual 1×1 Forum

    CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced that management will be participating in the 5th Annual Needham Private Biotech and MedTech Company Virtual 1×1 Forum taking place October 14-15, 2025.

    Apnimed will be hosting investor meetings virtually on Tuesday, October 14, and Wednesday, October 15.

    About Apnimed
    Apnimed is a privately held, clinical-stage pharmaceutical company based in Cambridge, Massachusetts, dedicated to transforming the treatment landscape for sleep-related breathing diseases. We believe the introduction of simple, once-nightly oral drugs may dramatically expand diagnosis and the reach of treatment for people with OSA. OSA, like other common chronic diseases such as diabetes or hypertension, would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment, and help more people get the oxygen and restorative sleep needed to thrive.

    Apnimed is advancing a robust pipeline of oral pharmaceutical product candidates designed to improve oxygenation in individuals living with OSA and other chronic sleep-related breathing diseases. Our lead candidate, AD109, could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. Apnimed is also developing several therapies as part of its joint venture with Shionogi & Co., Ltd., Shionogi-Apnimed Sleep Science.

    Learn more at apnimed.com or follow us on X and LinkedIn.

    Media Contact:
    [email protected]

    Investor Contact:
    [email protected]

    SOURCE Apnimed, Inc.

    Continue Reading

  • Stevia, The Natural Sugar Substitute, Could Help Keep Baldness At Bay

    Stevia, The Natural Sugar Substitute, Could Help Keep Baldness At Bay

    Stevia – the natural sugar substitute – may help boost hair loss treatment, suggests a new study in mice. Scientists developed a dissolving patch that contained a sweetener derived from the Stevia plant, which helped improve the efficacy of…

    Continue Reading

  • Top 5 run-getters from last India vs Australia ODI series in Australia: Shocking, Virat not even in top 3 – WION

    Top 5 run-getters from last India vs Australia ODI series in Australia: Shocking, Virat not even in top 3 – WION

    1. Top 5 run-getters from last India vs Australia ODI series in Australia: Shocking, Virat not even in top 3  WION
    2. 3 Australian bowlers who can be threat to Virat Kohli and Rohit Sharma’s ODI careers  OneCricket
    3. ODI history in numbers: India aim to…

    Continue Reading

  • Nigel Farage sends emotional message to King Charles

    Nigel Farage sends emotional message to King Charles



    Nigel Farage sends emotional message to King Charles

    King Charles III and senior members…

    Continue Reading

  • India beat South Korea to assure first-ever medal

    India beat South Korea to assure first-ever medal

    The Indian badminton team beat the Republic of Korea in the quarter-finals of the BWF World Junior Mixed Team Championships 2025 and confirmed a historic first-ever medal in the competition on Thursday.

    Competing at the National Centre of…

    Continue Reading

  • Missed Penalty Haunts Pakistan in Goalless Draw With Afghanistan in Asian Cup Qualifier

    Missed Penalty Haunts Pakistan in Goalless Draw With Afghanistan in Asian Cup Qualifier

    Pakistan’s hopes of reviving their AFC Asian Cup 2027 qualifying campaign suffered a frustrating blow as they were held to a 0-0 draw by Afghanistan at Jinnah Stadium.

    Despite creating the better chances, the home side were left to…

    Continue Reading

  • Diabetic Teens with High Blood Sugar Have Higher Neuropathy Risk in Adulthood

    BYLINE: Noah Fromson

    Newswise — Poor blood sugar control in adolescence increases the risk of painful future complications for people with type 1 diabetes, research co-led by…

    Continue Reading

  • Apple iPhone 17 Pro Max vs. Samsung Galaxy S25 Ultra: I tested both flagships, and here’s who wins

    Apple iPhone 17 Pro Max vs. Samsung Galaxy S25 Ultra: I tested both flagships, and here’s who wins

    Jason Hiner and Kerry Wan/ZDNET

    Follow ZDNET: Add us as a preferred source on Google.


    Apple last month announced its new iPhone 17 lineup at the Awe-Dropping Event in Cupertino, California. After years of playing it safe, the company is…

    Continue Reading

  • Tietoevry signs strategic multi-country agreement with Entercard

    Tietoevry signs strategic multi-country agreement with Entercard

    Tietoevry Industry has further deepened its Nordic collaboration by entering into a new multi-country agreement with Entercard, one of the region’s foremost credit card providers.

    Owned by Swedbank, Entercard has selected Tietoevry Industry to support its continued digital transformation across Norway, Sweden, Danmark and Finland. The five-year agreement (4+1), valued at approximately EUR 15–17 million, encompasses the delivery of Tietoevry’s advanced Multichannel services, alongside smart complementary solutions designed to accelerate Entercard’s digitalisation journey  

    “We are pleased to extend our partnership with Tietoevry. Having a trusted partner that can support us across Norway, Sweden, Finland, and beyond makes it easier for us to streamline operations and provide a consistent, high-quality experience to our customers throughout the Nordics. We look forward to continuing our collaboration and jointly developing services that meet both current and future needs,” said Geir Broum, Chief Information Officer, Entercard.  

    Smart communication and invoice distribution 

    Tietoevry Industry’s Multichannel platform is a robust document processing solution that enables efficient, flexible customer communication. It ensures that invoices, documents, and messages are delivered via the customer’s preferred channel – whether digital or physical – by integrating with digital mailboxes, payment services, and print providers. This empowers Entercard to optimise communication flows, reduce operational costs, and enhance customer experience. 

    This agreement reinforces Tietoevry’s position as a trusted digital partner within the Nordic financial services sector, delivering value-added solutions that drive both digital innovation and cost efficiency. 

    “We are proud to continue our long-standing partnership with Entercard. This agreement underscores our commitment to supporting their operations across the Nordics with reliable, forward-looking digital solutions. By working closely together, we help Entercard optimise communication and invoice processes while ensuring services are tailored to local markets and future-ready,” said Johan Enger Nygaard, Managing Director, Tietoevry Industry. 

    For more information, please contact 

    Tietoevry Newsdesk, news@tietoevry.com, tel. +358 40 570 4072 

    Tietoevry is a leading software and digital engineering services company with global market reach and capabilities. We provide customers across different industries with mission-critical solutions through our specialized software businesses Tietoevry Care, Tietoevry Banking and Tietoevry Industry, as well as our digital engineering business Tietoevry Create. Our around 15 000 talented vertical software, design, cloud and AI experts are dedicated to empowering our customers to succeed and innovate with latest technology. Tietoevry’s annual revenue is approximately EUR 2 billion. The company’s shares are listed on the NASDAQ exchange in Helsinki and Stockholm, as well as on Oslo Børs. www.tietoevry.com

     

    Continue Reading